Status:
RECRUITING
Taurine Effect on Glycemic, Lipidic and Inflammatory Profile in Individuals With Type 2 Diabetes
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
30-80 years
Phase:
PHASE2
Brief Summary
Type 2 diabetes mellitus (DM2) is characterized by chronic hyperglycemia, which is a risk factor for comorbidities and death. Although conventional pharmacotherapy is effective, some individuals do no...
Detailed Description
A randomized, double-blind, placebo-controlled clinical trial will be conducted at Hospital de Clínicas de Porto Alegre (HCPA), Brazil. A total of 94 participants with DM2 will be recruited and random...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Female and male individuals, with clinical diagnosis of DM2 for at least 6 months;
- Age over 30 years;
- BMC equal to or above 18.5 kg/m2, without weight change in the last 3 months;
- HbA1c between 7.5% and 10.5%.
- Exclusion criteria
- Use of herbal supplements, antioxidants, and multivitamins in the last 3 months;
- Pregnancy or lactation;
- Chronic renal failure with glomerular filtration rate calculated by MDRD \< 30 mL/h;
- Myocardial infarction in the last than 6 months
- Current neoplasia;
- Chronic use of glucocorticoids;
- Bariatric surgery.
Exclusion
Key Trial Info
Start Date :
June 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT04874012
Start Date
June 12 2021
End Date
December 1 2025
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital de Clínicas
Porto Alegre, Rio Grande do Sul, Brazil, 90630090